1. Home
  2. IMRN vs MDJH Comparison

IMRN vs MDJH Comparison

Compare IMRN & MDJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • MDJH
  • Stock Information
  • Founded
  • IMRN 1994
  • MDJH 2002
  • Country
  • IMRN Australia
  • MDJH United Kingdom
  • Employees
  • IMRN N/A
  • MDJH N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • MDJH Real Estate
  • Sector
  • IMRN Health Care
  • MDJH Finance
  • Exchange
  • IMRN Nasdaq
  • MDJH Nasdaq
  • Market Cap
  • IMRN 15.0M
  • MDJH 13.6M
  • IPO Year
  • IMRN N/A
  • MDJH 2019
  • Fundamental
  • Price
  • IMRN $2.20
  • MDJH $0.61
  • Analyst Decision
  • IMRN Strong Buy
  • MDJH
  • Analyst Count
  • IMRN 1
  • MDJH 0
  • Target Price
  • IMRN $5.00
  • MDJH N/A
  • AVG Volume (30 Days)
  • IMRN 6.6K
  • MDJH 46.6K
  • Earning Date
  • IMRN 10-22-2024
  • MDJH 01-01-0001
  • Dividend Yield
  • IMRN N/A
  • MDJH N/A
  • EPS Growth
  • IMRN N/A
  • MDJH N/A
  • EPS
  • IMRN N/A
  • MDJH N/A
  • Revenue
  • IMRN $3,271,194.00
  • MDJH $114,849.00
  • Revenue This Year
  • IMRN N/A
  • MDJH N/A
  • Revenue Next Year
  • IMRN N/A
  • MDJH N/A
  • P/E Ratio
  • IMRN N/A
  • MDJH N/A
  • Revenue Growth
  • IMRN 171.67
  • MDJH 289.97
  • 52 Week Low
  • IMRN $1.48
  • MDJH $0.59
  • 52 Week High
  • IMRN $5.96
  • MDJH $2.19
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 29.63
  • MDJH 31.54
  • Support Level
  • IMRN $2.66
  • MDJH $0.62
  • Resistance Level
  • IMRN $2.87
  • MDJH $0.68
  • Average True Range (ATR)
  • IMRN 0.14
  • MDJH 0.05
  • MACD
  • IMRN -0.06
  • MDJH 0.01
  • Stochastic Oscillator
  • IMRN 1.50
  • MDJH 4.01

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About MDJH MDJM LTD

MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.

Share on Social Networks: